Your browser doesn't support javascript.
loading
Adverse perinatal outcome and placental abnormalities in pregnancies with major fetal congenital heart defects: A retrospective case-control study.
Giorgione, Veronica; Fesslova, Vlasta; Boveri, Sara; Candiani, Massimo; Khalil, Asma; Cavoretto, Paolo.
Afiliación
  • Giorgione V; Department of Obstetrics and Gynecology, IRCCS San Raffaele Hospital, Vita-Salute University, Milan, Italy.
  • Fesslova V; Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK.
  • Boveri S; Center of Fetal Cardiology, IRCCS Policlinico San Donato, Milan, Italy.
  • Candiani M; Scientific Directorate, IRCCS Policlinico San Donato, Milan, Italy.
  • Khalil A; Department of Obstetrics and Gynecology, IRCCS San Raffaele Hospital, Vita-Salute University, Milan, Italy.
  • Cavoretto P; Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK.
Prenat Diagn ; 40(11): 1390-1397, 2020 10.
Article en En | MEDLINE | ID: mdl-32557693
OBJECTIVE: The placental development has been shown to be compromised in pregnancies affected by fetal congenital heart defects (CHD). This study aimed to investigate the frequency of complications related to utero-placental insufficiency in pregnancies with and without major CHD. METHOD: This retrospective case-control study was conducted at a Fetal Echocardiography Center in Milan. The following outcomes were compared between the two groups: preeclampsia (PE), small for gestational age (SGA), placental disorders and preterm birth (PTB). The logistic regression analysis was adjusted for maternal age, parity, co-morbidities and mode of conception. RESULTS: The CHD group (n = 480) showed significantly increased incidence of PE (2.9% vs 0.9%; aOR, 6.50; 95% CI, 1.39-30.41; P = .017) as compared to the control group (n = 456). Placental disorders occurred more frequently in the CHD than in controls, but the increased risk showed only a borderline significance (4.5% vs 3.3%; aOR, 2.56; 95% CI, 0.99-1.02; P = .046). There was a significantly higher risk of SGA in CHD than in controls (8.7% vs 3.9%; aOR, 3.37; 95% CI, 1.51-7.51; P = .003). PTB occurred in 65/477 (13.6%) cases and in 39/447 (8.7%) controls (P = .022) (aOR, 2.17; 95% CI, 1.24-3.81; P = .007). CONCLUSION: Major CHD are significantly associated with the risk of PE, SGA and PTB.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Placentarias / Nacimiento Prematuro / Enfermedades Fetales / Cardiopatías Congénitas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Pregnancy País/Región como asunto: Europa Idioma: En Revista: Prenat Diagn Año: 2020 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Placentarias / Nacimiento Prematuro / Enfermedades Fetales / Cardiopatías Congénitas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Pregnancy País/Región como asunto: Europa Idioma: En Revista: Prenat Diagn Año: 2020 Tipo del documento: Article País de afiliación: Italia